Omega Fund Management, LLC

报告期 2026-03-31 · CIK 0001637359

持仓数

前50大市值合计

$163.1M

报告期

2026-03-31

当前持仓调仓

前 10 大持仓

标的

类型

市值

股数

占比*

BCAX Bicara Therapeutics Inc.

Common Stock

$47.6M

2,392,150

29.2%

NUVB Nuvation Bio Inc.

Common Stock Class A

$34.7M

8,081,089

21.2%

BBOT BridgeBio Oncology Therapeutics Inc.

Common Stock

$29.4M

3,289,661

18.0%

— Kestra Med Technologies Ltd

Common Stock

$20.4M

1,022,149

12.5%

BBNX Beta Bionics Inc.

Common Stock

$13.2M

1,316,183

8.1%

— enGene Holdings Inc.

Common Stock

$6.0M

876,357

3.7%

ALMS Alumis Inc.

Common Stock

$5.3M

241,255

3.3%

SANA Sana Biotechnology, Inc.

Common Stock

$2.4M

843,750

1.5%

IMA ImageneBio, Inc.

Common Stock

$2.3M

455,361

1.4%

REPL Replimune Group

Common Stock

$1.9M

248,672

1.2%

* 占比按本页前 50 大持仓市值合计计算

持仓集中度按前 50 大市值

93%前 6 大占比

BCAX29.2%NUVB21.2%BBOT18.0%Kestra Med Technologies Ltd12.5%BBNX8.1%enGene Holdings Inc.3.7%